- Home
- PRVA
as 12-20-2024 3:41pm EST
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 2.5B | IPO Year: | 2021 |
| Target Price: | $24.46 | AVG Volume (30 days): | 655.3K |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | -64.75 |
| 52 Week Low/High: | $15.92 - $24.30 | Next Earning Date: | 11-07-2024 |
| Revenue: | $1,716,318,000 | Revenue Growth: | 8.54% |
| Revenue Growth (this year): | 78.44% | Revenue Growth (next year): | 11.43% |
Latest Privia Health Group Inc. News
PRVA Breaking Stock News: Dive into PRVA Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
DH vs. PRVA: Which Stock Is the Better Value Option?
Argus Research
5 days ago
PRVA: Lowering target price to $22.00
Simply Wall St.
5 days ago
3 US Stocks That May Be Trading Below Their Estimated Value
MT Newswires
6 days ago
Macquarie Initiates Privia Health Group at Outperform With $25 Price Target
The Fly
6 days ago
Netflix, MongoDB downgraded: Wall Street's top analyst calls
Argus Research
12 days ago
PRVA: What does Argus have to say about PRVA?
Simply Wall St.
18 days ago
Privia Health Group Insiders Placed Bullish Bets Worth US$9.31m
Zacks
18 days ago
DH vs. PRVA: Which Stock Should Value Investors Buy Now?
Compare PRVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.